The important role that EGFR plays in asthma is also underscored by studies showing that tyrosine kinase inhibitors such as gefitnib, erlotinibin and AG1478, inhibit both EGFR phosphorylation and asthma features such as cellular influx and airway remodeling and AHR [4, 27, 62]. Here, EGFR is linked to asthma.